Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine
Frédéric Coutant, Marie-Pascale Frenkiel, Philippe Despres et al. · 2008
Read Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine by Frédéric Coutant, Marie-Pascale Frenkiel, Philippe Despres et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003973.txt.
Description
Frédéric Coutant, Marie-Pascale Frenkiel, Philippe Despres, and co-authors tested a safer viral vaccine carrier in 2008. Lentiviral vectors can start strong, lasting immune responses. That makes them attractive carriers for vaccines against tumors and tough germs. Safety worries have slowed their move into clinics.
Their PLOS ONE article uses a vector that does not integrate into cell DNA. Integration is the step feared to cause harm over time. The nonintegrative vaccine still conferred protective antiviral immunity in their tests. A safer carrier could widen use of this vaccine platform. The study ran in PLOS ONE, an open journal read by labs around the world.
Catalog record
| CREATOR | Frédéric Coutant, Marie-Pascale Frenkiel, Philippe Despres et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003973